Allakos Investigational Site

Cincinnati, Ohio 45231

0 studies enrolling now · 5 studies all time

What they study most

Chronic Urticaria, Eosinophilic Duodenitis, Eosinophilic Esophagitis, Eosinophilic Gastritis, Eosinophilic Gastroenteritis

Studies at this site

• A Study to Assess the Efficacy and Safety of AK002 in Subjects With Antihistamine-Resistant Chronic Urticaria — Completed
• A Study to Assess AK002 in Eosinophilic Gastritis and/or Eosinophilic Duodenitis (Formerly Referred to as Eosinophilic Gastroenteritis) — Completed
• A Study of Lirentelimab (AK002) in Patients With Active Eosinophilic Esophagitis — Completed
• A Study of Lirentelimab (AK002) in Patients With Active Eosinophilic Duodenitis — Completed
• A Study to Assess Subcutaneous AK002 in Eosinophilic Gastritis and/or Eosinophilic Duodenitis — Withdrawn before enrolling